Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

RANKL blockade attenuates MASH by remodeling the hepatic immune microenvironment

Abstract

ObjectiveMetabolic dysfunction-associated steatohepatitis (MASH) is a leading cause of chronic liver disease worldwide and is largely driven by chronic inflammation and hepatic immune dysregulation. The receptor activator of nuclear factor-κB ligand (RANKL) is a master regulator of bone metabolism with emerging immunomodulatory functions. Although growing evidence links the RANK-RANKL-OPG axis to MASH pathophysiology, whether RANKL blockade attenuates MASH development remains unclear. This study therefore investigated the effects and underlying mechanisms of RANKL blockade in a mouse model of MASH.MethodsMale mice were fed a choline-deficient high-fat diet (CDHFD) for 16 weeks to induce MASH and were treated with the RANKL-neutralizing antibody IK22/5 (1, 4, or 8 mg/kg) or an IgG control. Metabolic parameters, liver histology, and biochemical markers were assessed. Hepatic immune-cell infiltration was analyzed using CIBERSORT-based deconvolution, and immune populations were characterized by flow cytometry. Transcriptomic profiling identified RANKL-regulated genes, followed by cross-species analysis using human MASH datasets.ResultsRANKL blockade dose-responsively improved glucose tolerance, hepatic steatosis, inflammation, and fibrosis. Transcriptomic analysis identified 48 genes that were dysregulated in MASH but reversed by RANKL blockade; these genes were enriched in lipid metabolism, immune regulation, and fibrosis pathways. Immune profiling revealed broad remodeling of the hepatic immune microenvironment: IK22/5 reduced CD11bhighF4/80+ monocyte-derived macrophages, CD86+ M1-like macrophages, CD3-NK1.1+ NK cells, and CD3+NK1.1+CD4-CD8- NKT-like cells, while increasing γδ T cells and preserving CD11bintF4/80+Tim4+ Kupffer cells. Immunofluorescence showed that RANKL blockade significantly reduced hepatic CD74+F4/80+ macrophages, together with decreased expression of other lipid-associated macrophage markers.ConclusionsOverall, these findings indicate that RANKL blockade attenuated MASH development and support RANKL as a potential immune–metabolic regulator, providing a preclinical rationale for further evaluation of RANKL-targeted strategies in clinically relevant models.

Related

  1. Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface
    Vasileios Alexandros Karakousis, Antonia Sioga, Ioannis S. Vizirianakis +4
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  2. Saccharomyces boulardii reduces food intake and attenuates weight gain in diet-induced obese mice: links to gut microbial, metabolic, and immune remodeling
    Karl Alex Hedin, Troels Holger Vaaben, Ditte Olsen Lützhøft +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  3. Remodeling of the brain immune microenvironment in Alzheimer’s disease: interactions among microglia, astrocytes, complement, and the neurovascular unit
    Tong Wang, Lu Wang, Jianing Cao +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Tumor cell-intrinsic mtDNA instability drives cGAS-dependent temporal remodeling of the melanoma immune microenvironment
    A. Bashaw, A. Winters, Y. Lei +11
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  5. Mechanical‑immune feedback regulation in distraction osteogenesis: From mechanotransduction to immune microenvironment remodeling (Review).
    Xian Wang, Yuetong Wang, Shixi He +3
    Molecular medicine reportsPeer-reviewedCC BY-NC-NDFull textGenetics & genomicsEurope PMC
BibTeX
@article{wang2026rankl,
  title = {{RANKL blockade attenuates MASH by remodeling the hepatic immune microenvironment}},
  author = {Junxue Wang and Ningjia Yang and Huixia Li and Sijia Dan and Hui Guo and Kexi Zha and Fangzhen Xia},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = nov,
  doi = {10.3389/fimmu.2026.1901751},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1901751},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - RANKL blockade attenuates MASH by remodeling the hepatic immune microenvironment
AU  - Junxue Wang
AU  - Ningjia Yang
AU  - Huixia Li
AU  - Sijia Dan
AU  - Hui Guo
AU  - Kexi Zha
AU  - Fangzhen Xia
PY  - 2026
DA  - 2026/11/05
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1901751
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1901751
AB  - ObjectiveMetabolic dysfunction-associated steatohepatitis (MASH) is a leading cause of chronic liver disease worldwide and is largely driven by chronic inflammation and hepatic immune dysregulation. The receptor activator of nuclear factor-κB ligand (RANKL) is a master regulator of bone metabolism with emerging immunomodulatory functions. Although growing evidence links the RANK-RANKL-OPG axis to MASH pathophysiology, whether RANKL blockade attenuates MASH development remains unclear. This study therefore investigated the effects and underlying mechanisms of RANKL blockade in a mouse model of MASH.MethodsMale mice were fed a choline-deficient high-fat diet (CDHFD) for 16 weeks to induce MASH and were treated with the RANKL-neutralizing antibody IK22/5 (1, 4, or 8 mg/kg) or an IgG control. Metabolic parameters, liver histology, and biochemical markers were assessed. Hepatic immune-cell infiltration was analyzed using CIBERSORT-based deconvolution, and immune populations were characterized by flow cytometry. Transcriptomic profiling identified RANKL-regulated genes, followed by cross-species analysis using human MASH datasets.ResultsRANKL blockade dose-responsively improved glucose tolerance, hepatic steatosis, inflammation, and fibrosis. Transcriptomic analysis identified 48 genes that were dysregulated in MASH but reversed by RANKL blockade; these genes were enriched in lipid metabolism, immune regulation, and fibrosis pathways. Immune profiling revealed broad remodeling of the hepatic immune microenvironment: IK22/5 reduced CD11bhighF4/80+ monocyte-derived macrophages, CD86+ M1-like macrophages, CD3-NK1.1+ NK cells, and CD3+NK1.1+CD4-CD8- NKT-like cells, while increasing γδ T cells and preserving CD11bintF4/80+Tim4+ Kupffer cells. Immunofluorescence showed that RANKL blockade significantly reduced hepatic CD74+F4/80+ macrophages, together with decreased expression of other lipid-associated macrophage markers.ConclusionsOverall, these findings indicate that RANKL blockade attenuated MASH development and support RANKL as a potential immune–metabolic regulator, providing a preclinical rationale for further evaluation of RANKL-targeted strategies in clinically relevant models.
SN  - 1664-3224
ER  -